Iron deficiency limits hydroxyurea-induced fetal hemoglobin and clinical efficacy in sickle cell disease | Blood | American Society of Hematology ashpublications.org/blood/ar…
Single Cell Hemoglobin Quantification Reveals HbF and HbS Increases in Sickle Erythrocytes from Patients Treated with Hydroxyurea | Blood | American Society of Hematology ashpublications.org/blood/ar…
📣We are pleased to announce that RADeep will participate in the 67th #ASH Annual Meeting and Exposition!
✅This year, we will present four key contributions focused on real-world data, outcome research in hemoglobinopathies, and Europe-wide data standardization efforts.
Kanter J, et al. Implementing linkage coordination: Patient experiences in the recruitment and engagement in care to impact practice enhancement (RECIPE) for SCD study
How this translates to less acute care would be important.
doi.org/10.1182/blood-2025-1…#ASH25
Chawla A, et al. Accelerating access to gene therapy: Lessons from commercial implementation in sickle cell disease and transfusion-dependent thalassemia
doi.org/10.1182/blood-2025-9…#ASH25
Miranda M, et al. The weight of stress: Allostatic load as a predictor of vaso-occlusive episodes in adults with sickle cell disease
doi.org/10.1182/blood-2025-1…#ASH25
Sanni A, et al. A united-states nationwide analysis of sickle cell genotype-specific differences in inpatient outcomes
Some results are thought provoking despite methodological limits. Absolute risk of death was not published but essential.
doi.org/10.1182/blood-2025-9…#ASH25
📍Dr. María del Mar Mañú Pereira (RADeep Coordinator and Scientific Coordinator of the @ERNEuroBloodNet & #ENROL) presented “Towards ethical AI in Rare Diseases: data quality and clinical validation for real equity” at the XXXI National Congress on Health Law in Madrid, Spain.